Clinical trial

The Safety and Dosimetry Study of 177Lu-LNC1003 Injection

NCT06237491

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2025-05-07

PhasePHASE1

Study timeline

Study start (estimated)2025-05-07Date precision: day

Registry last updated2024-07-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Castration-resistant Prostate Cancer, mCRPCunresolved

Interventions

177Lu-LNC1003 Injection group 1DRUG

177Lu-LNC1003 Injection group 2DRUG

177Lu-LNC1003 Injection group 3DRUG

Sponsors & collaborators

Yantai LNC Biotechnology Singapore PTE. LTD.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06237491 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.